FIPREX DUO XL 402 mg + 361.8 mg spot-on solution for dogs България - български - БАБХ (Българска агенция по безопасност на храните)

fiprex duo xl 402 mg + 361.8 mg spot-on solution for dogs

vet-agro multi trade company sp. z o.o. - Фипронил (с)-метопрен - разтвор за прилагане върху ограничен участък - 402.00 mg/0.5 ml; 361.8 mg/0.5 ml - кучета

KABERGOVET 50 microgram/ml oral solution for dogs and cats 50 microgram/ml България - български - БАБХ (Българска агенция по безопасност на храните)

kabergovet 50 microgram/ml oral solution for dogs and cats 50 microgram/ml

vet-agro multi-trade company sp. z o.o. - Каберголин - перорален разтвор - 50 microgram/ml - котки, кучета

Blincyto Европейски съюз - български - EMA (European Medicines Agency)

blincyto

amgen europe b.v. - blinatumomab - Прекурсорна клетъчна лимфобластна левкемия-лимфом - Антинеопластични средства - blincyto is indicated as monotherapy for the treatment of adults with cd19 positive relapsed or refractory b precursor acute lymphoblastic leukaemia (all). patients with philadelphia chromosome positive b-precursor all should have failed treatment with at least 2 tyrosine kinase inhibitors (tkis) and have no alternative treatment options. blincyto is indicated as monotherapy for the treatment of adults with philadelphia chromosome negative cd19 positive b-precursor all in first or second complete remission with minimal residual disease (mrd) greater than or equal to 0. blincyto is indicated as monotherapy for the treatment of paediatric patients aged 1 year or older with philadelphia chromosome negative cd19 positive b precursor all which is refractory or in relapse after receiving at least two prior therapies or in relapse after receiving prior allogeneic haematopoietic stem cell transplantation. blincyto is indicated as monotherapy for the treatment of paediatric patients aged 1 year or older with high-risk first relapsed philadelphia chromosome negative cd19 positive b-precursor all as part of the consolidation therapy (see section 4.

Kyprolis Европейски съюз - български - EMA (European Medicines Agency)

kyprolis

amgen europe b.v. - carfilzomib - Множествена миелома - Антинеопластични средства - kyprolis in combination with daratumumab and dexamethasone, with lenalidomide and dexamethasone, or with dexamethasone alone is indicated for the treatment of adult patients with multiple myeloma who have received at least one prior therapy.

METRONIDAVET 250 mg tablets for dogs and cats България - български - БАБХ (Българска агенция по безопасност на храните)

metronidavet 250 mg tablets for dogs and cats

vet-agro multi-trade company sp. z o.o. - Метронидазол - таблетка - 250 mg/таблетка - котки, кучета

METRONIDAVET 500 mg tablets for dogs and cats България - български - БАБХ (Българска агенция по безопасност на храните)

metronidavet 500 mg tablets for dogs and cats

vet-agro multi-trade company sp. z o.o. - Метронидазол - таблетка - 500 mg/таблетка - котки, кучета

THYROXAVET  200 microgram tablets for dogs and cats България - български - БАБХ (Българска агенция по безопасност на храните)

thyroxavet 200 microgram tablets for dogs and cats

vet-agro multi-trade company sp. z o.o. - Левотироксин натрий - таблетка - 200 µg/таблетка - кучета

THYROXAVET 400 microgram tablets for dogs and cats България - български - БАБХ (Българска агенция по безопасност на храните)

thyroxavet 400 microgram tablets for dogs and cats

vet-agro multi-trade company sp. z o.o. - Левотироксин натрий - таблетки - 400 µg/таблетки - кучета

THYROXAVET 800 microgram tablets for dogs България - български - БАБХ (Българска агенция по безопасност на храните)

thyroxavet 800 microgram tablets for dogs

vet-agro multi-trade company sp. z o.o. - Левотироксин натрий - таблетка - 800 µg/таблетка - кучета